The Company

FONKO International Pharmaceuticals is part of the Dexa Group. Established in 2010, FONKO International Pharmaceuticals is intended to be a manufacturing arm of the group with a focus of supplying quality oncology products to the world.

Dexa Group is a major pharmaceutical group in Indonesia. It started from a small manufacturing operation in 1969. Currently the group is a well established group reputed in supplying a diverse range of pharmaceuticals to Indonesia and beyond.

Dexa Group is an integrated group, having an RnD facility, wide range of manufacturing capabilities and marketing teams as well as distribution infrastructure covering the vast geographical area of Indonesia. Dexa Group is also represented in the ASEAN region and other parts of the world. The RnD capability of Dexa Group has the capability of dossier development for ASEAN as well as European CTD.

One of the manufacturing facilities under the company of FERRON Par Pharmaceuticals, has been certified by MHRA, TGA and the state of Hanover, Germany.

 

PT Fonko International Pharmaceuticals

Vision:
To attain a reputable source of quality oncology products locally, regionally and globally.

Mission:
1. Consistent compliance to global regulatory requirements for uncompromising quality
2. Dynamic collaboration network and flexible business model to realize value in sourcing, development, as well as supply of products to the global
    oncology market.
3. Efficient and safe manufacturing processes for value and competitiveness.
4. Professional and caring work culture with agile and astute human resources for excellence.

 

Factory Address:
Kawasan Jababeka II, Jl. Industri Selatan 5, Blok PP 7
Cikarang, Bekasi, Jawa Barat, Indonesia 17550